Toward Smarter Lumping and Smarter Splitting: Rethinking Strategies for Sepsis and Acute Respiratory Distress Syndrome Clinical Trial Design
Top Cited Papers
- 15 July 2016
- journal article
- review article
- Published by American Thoracic Society in American Journal of Respiratory and Critical Care Medicine
- Vol. 194 (2), 147-155
- https://doi.org/10.1164/rccm.201512-2544cp
Abstract
Both quality improvement and clinical research efforts over the past few decades have focused on consensus definition of sepsis and acute respiratory distress syndrome (ARDS). Although clinical definitions based on readily available clinical data have advanced recognition and timely use of broad supportive treatments, they likely hinder the identification of more targeted therapies that manipulate select biological mechanisms underlying critical illness. Sepsis and ARDS are by definition heterogeneous, and patients vary in both their underlying biology and their severity of illness. We have long been able to identify subtypes of sepsis and ARDS that confer different prognoses. The key is that we are now on the verge of identifying subtypes that may confer different response to therapy. In this perspective, inspired by a 2015 American Thoracic Society International Conference Symposium entitled “Lumpers and Splitters: Phenotyping in Critical Illness,” we highlight promising approaches to uncovering patient subtypes that may predict treatment responsiveness and not just differences in prognosis. We then discuss how this information can be leveraged to improve the success and translatability of clinical trials by using predictive enrichment and other design strategies. Last, we discuss the challenges and limitations to identifying biomarkers and endotypes and incorporating them into routine clinical practice.Keywords
This publication has 60 references indexed in Scilit:
- Multiplex PCR System for Rapid Detection of Pathogens in Patients with Presumed Sepsis – A Systemic Review and Meta-AnalysisPLOS ONE, 2013
- Toward a clinically feasible gene expression-based subclassification strategy for septic shock: Proof of conceptCritical Care Medicine, 2010
- Pharmacological treatments for acute respiratory distress syndromeCurrent Opinion in Critical Care, 2010
- Gene expression profiling: Classification of mice with left ventricle systolic dysfunction using microarray analysis*Critical Care Medicine, 2010
- Clinical phenotype of cystic fibrosis patients with the G551D mutationQJM: An International Journal of Medicine, 2009
- Identification of pediatric septic shock subclasses based on genome-wide expression profilingBMC Medicine, 2009
- Pharmacogenetic Principles in the Hippocratic WritingsThe Journal of Clinical Pharmacology, 2005
- 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions ConferenceIntensive Care Medicine, 2003
- Ventilation with Lower Tidal Volumes as Compared with Traditional Tidal Volumes for Acute Lung Injury and the Acute Respiratory Distress SyndromeThe New England Journal of Medicine, 2000
- Pro‐ versus Anti‐inflammatory Cytokine Profile in Patients with Severe Sepsis: A Marker for Prognosis and Future Therapeutic OptionsThe Journal of Infectious Diseases, 2000